Evidence map›Paper›PMID 26624849›Full record

ReviewInfectious diseases (London, England)2016

Treatment of hepatitis C virus infection for adults and children: Updated Swedish consensus recommendations.

Martin Lagging, Rune Wejstål, Gunnar Norkrans, Olle Karlström, Soo Aleman, Ola Weiland, Maria Castedal, Filip Josephson, Swedish Consensus Group

Abstract readReviewConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Review in Infectious diseases (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. [Application of direct antiviral drugs in special patients with HCV infection].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2018
    Review
  4. Cryoglobulin Test and Cryoglobulinemia Hepatitis C-Virus Related.Mediterranean journal of hematology and infectious diseases · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Martin Lagginga Department of Infectious Medicine , Institute of Biomedicine at Sahlgrenska Academy, University of Gothenburg , Gothenburg , Sweden.
Rune Wejståla Department of Infectious Medicine , Institute of Biomedicine at Sahlgrenska Academy, University of Gothenburg , Gothenburg , Sweden.
Gunnar Norkransa Department of Infectious Medicine , Institute of Biomedicine at Sahlgrenska Academy, University of Gothenburg , Gothenburg , Sweden.
Olle Karlströmc Medical Products Agency , Uppsala , Sweden.
Soo Alemand Department of Infectious Diseases , Karolinska University Hospital , Stockholm , Sweden.
Ola Weilandd Department of Infectious Diseases , Karolinska University Hospital , Stockholm , Sweden.
Maria Castedale Transplant Institute, Sahlgrenska University Hospital and Sahlgrenska Academy, University of Gothenburg , Gothenburg , Sweden.
Filip Josephsonc Medical Products Agency , Uppsala , Sweden.
Swedish Consensus Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a recent expert meeting, Swedish recommendations for the treatment of HCV infection were updated. An interferon-free combination of direct-acting antiviral agents was recommended as the first line standard-of-care treatment for chronic HCV infection. Interferon-based therapy should be considered as a second line option after an individual benefit-risk assessment. Treatment is strongly recommended for HCV infected patients with bridging fibrosis or cirrhosis (Metavir stages F3-4), before and after liver transplantation, and in the presence of extra-hepatic manifestations. Additionally, patients with moderate liver fibrosis (stage F2) as well as women in need of in vitro fertilisation should be prioritised for therapeutic intervention. Treatment indications for people who inject drugs, children, chronic kidney disease and HIV co-infection are also discussed.

Indexed as

AdolescentAdultChildChild, PreschoolFemaleHepacivirusHepatitis CHepatitis C, ChronicHumansInfantMaleSwedenchildrenchronic kidney diseaseDAA, people who inject drugsdirect-acting antiviral agentsguidelinesHCVHepatitis C virusHIV co-infection

Identifiers

PMID26624849
PMCPMC4732459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.